MI - Cases Burden
The main risk factors for MI include genetic susceptibility and non-genetic factors such as hypertension, obesity, diabetes and lifestyle (5–10).More 75 % of CVD deaths occur in low and middle-income countries.
The annual no of deaths from CVD is projected to rise from 2.26 million (1990) to 4.77 million (2020). .
Over 75% of CVD deaths take place in low- and middle-income countries where raised blood pressure happens to be amongst the most important risk factors for CVDs.
An estimated 17.9 million people died from CVDs in 2019, representing 32% of all global deaths. Of these deaths, 85% were due to heart attack and stroke.
More than four out of five CVD deaths are due to heart attacks and strokes, and one third of these deaths occur prematurely in people under 70 years of age.
OLEMUS
Perfect Cardiac Companion
Features
Key Features
Reliability
A reliable point of care foolproof technology to check complete heart vitals at home.
Robust
Robust optics-based plasmon technology to give accurate results in minutes.
Ergonomic
Ergonomic design and user-friendly device with ease of handling
Aesthetic
Aesthetic design and user interface to provide the best home care diagnosis.
Intuitive
Intuitive cardiac companion device with alarming technology to connect you to doctors.
Accurate
High accuracy and instant results with gold standard cardiac biomarkers with implemented compliance standards and cGMP guidelines.
AI-powered
The Olemus Cardio care companion has an AI-powered algorithm to detect an differentiate varieties of cardiovascular disorders.
Integrated ECG
Along with gold standard biomarkers analysis ECG is also integrated for complete and detailed analysis of heart vitals ensuring a fool-proof methodology.
Cloud Enabled
This device comes with a cloud integration to store and retrieve data whenever needed for better heath care.
Scientifically Backed
Learn more about the company, "Scientific Backings", CVD point of care devices market etc from below link.
Learn More
The Problem we solve
The Olemus device in this start up is designed to encounter the MI (Myocardial Infraction) simply known as heart attack.
This disorder occurs in various ways basing on diet, work, habits and pre and post clinical procedures irrespective of age, sex and time.
The Way Forward
To create a POC device.
To screen cardiac injury markers by and determining the specificity with ELISA.
To establish the specificity with gold standard SPR as a validation of biomarkers.
The Sales and Marketing Plan
This device comes 3 main service features ie diagnosis by biomarkers, ECG, expert consultation
which generally cost 3100 rs per person per test through regular procedures.
Whereas combining these 3 in to single device having the price 18,499 rs per patient per price will generally costs an equivalent of 6 checkups on regular basis.
The Value Proposition
In contrast to conventional lab-based diagnosis, SPR offers label-free detection, No harm, no radiation, and no complex lab equipment or experts to use them.
The manufacturing cost is low, ultimately reducing the MRP of purchase for end-users.
About
About Us
About The Start Up.
This startup aims to design various biosensor devices which are the latest technological solutions to diagnose diseases and disorders at home scale by the end users (patients), we aim to develop our first biosensor to screen cardiac disorders which have a very high impact on global population.
- The all in one cardiac screening device which is named as Olemus is the first of its kind in among many other point of care devices to integrate an AI and all in one system of biochemical and physiological based screening for cardiac disorders.
- According to our market research the biosensors market for POC applications holds the largest market share in 2021.
- POC applications are included in glucose monitoring, cardiac marker, infectious disease detection, and coagulation monitoring, among others.
- Technological advancements in POC devices, rising incidences of infectious diseases.
The point of care device with this specific combination of both diagnostic and prognostic utility has immense potential to create multiple market avenues for the medical fraternity like diagnostic centers and hospital chains. Moreover, with an additional boost of untapped capability in the staggering $ 42.4 billion cardiovascular device market standalone in India.
Team
Our Team
K. Venkata Atchuta Rao
Managing Director Principle Researcher
Dr. L. Chandra Mouli
Director Facilitating Partner
Mr. Krishna Sai Inkoolu
Professional Director Product Designer
Dr. Rahul Kumar
Knowledge Partner
Dr. Pradeep Kumar
Principle Advisor
Dr. Pradeep
FACC, FIACS, CPDH IISC, GLOBAL MBA,MCh ( AIIMS ) , PDF ( SCTIMST ).PDF ECMO (ISCVU)
Best point of care device to reduce door-to-needle time of CVD patients..
Dr. Atul
Cardiologist
The device incorporates the latest nanotech with biochemical and physiological-based analysis as foolproof technology developed by the finest team of INDQ .
FAQ
FREQUENTLY ASKED QUESTIONS
Contact
Contact Us
Location:
LVPEI Incubator, GPRICARE Campus Hydrabad, Telangana, -500030
Email:
olemus@indq.com
Call:
+91 93465 89448
